RT Journal Article
SR Electronic
T1 First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC)
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e005702
DO 10.1136/jitc-2022-005702
VO 11
IS 3
A1 Autio, Karen A
A1 Higano, Celestia S
A1 Nordquist, Luke
A1 Appleman, Leonard J
A1 Zhang, Tian
A1 Zhu, Xin-Hua
A1 Babiker, Hani
A1 Vogelzang, Nicholas J
A1 Prasad, Sandip M
A1 Schweizer, Michael T
A1 Madan, Ravi A
A1 Billotte, Stephane
A1 Cavazos, Nora
A1 Bogg, Orlaith
A1 Li, Ray
A1 Chan, Kam
A1 Cho, Helen
A1 Kaneda, Megan
A1 Wang, I-Ming
A1 Zheng, Jenny
A1 Tang, Szu-Yu
A1 Hollingsworth, Robert
A1 Kern, Kenneth A
A1 Petrylak, Daniel P
YR 2023
UL http://jitc.bmj.com/content/11/3/e005702.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.